[1] SIEGEL RL,MILLER KD,WAGLE NS,et al.Cancer statistics,2023[J].CA Cancer J Clin,2023,73(1):17-48.
[2] MORAND S,DEVANABOYINA M,STAATS H,et al.Ovarian cancer immunotherapy and personalized medicine[J].Int J Mol Sci,2021,22(12):6532.
[3] CHANDRA A,PIUS C,NABEEL M,et al.Ovarian cancer:Current status and strategies for improving therapeutic outcomes[J].Cancer Med,2019,8(16):7018-7031.
[4] MATTICK JS,AMARAL PP,CARNINCI P,et al.Long non-coding RNAs:definitions,functions,challenges and recommendations[J].Nat Rev Mol Cell Biol,2023,24(6):430-447.
[5] LIANG H,YU T,HAN Y,et al.LncRNA PTAR promotes EMT and invasion-metastasis in serous ovarian cancer by competitively binding miR-101-3p to regulate ZEB1 expression[J].Mol Cancer,2018,17(1):119.
[6] ZHAO Y,YUAN D,ZHU D,et al.LncRNA-MSC-AS1 inhibits the ovarian cancer progression by targeting miR-425-5p[J].J Ovarian Res,2021,14(1):109.
[7] PENG Y,HUANG X,WANG H.Serum lncRNA LINC01535 as biomarker of diagnosis,prognosis,and disease progression in breast cancer[J].Clin Breast Cancer,2023,23(6):620-627.
[8] YAO X,WU L,GU Z,et al.LINC01535 promotes the development of osteosarcoma through modulating miR-214-3p/KCNC4 axis[J].Cancer Manag Res,2020,12:5575-5585.
[9] ZHAO C,JIANG Q,CHEN L,et al.LncRNA LINC01535 promotes colorectal cancer development and chemoresistance by sponging miR-761[J].Exp Ther Med,2021,22(1):685.
[10] FANG Y,ZHANG S,YIN J,et al.LINC01535 promotes proliferation and inhibits apoptosis in esophageal squamous cell cancer by activating the JAK/STAT3 pathway[J].Eur Rev Med Pharmacol Sci,2020,24(7):3694-3700.
[11] SONG H,LIU Y,JIN X,et al.Long non-coding RNA LINC01535 promotes cervical cancer progression via targeting the miR-214/EZH2 feedback loop[J].J Cell Mol Med,2019,23(9):6098-6111.
[12] GAO L,LI X,NIE X,et al.Construction of novel mRNA-miRNA-lncRNA regulatory networks associated with prognosis of ovarian cancer[J].J Cancer,2020,11(23):7057-7072.
[13] GYORFFY B.Discovery and ranking of the most robust prognostic biomarkers in serous ovarian cancer[J].Geroscience,2023,45(3):1889-1898.
[14] NAGHSH-NILCHI A,EBRAHIMI GL,DEHGHANIAN F.Construction of miRNA-lncRNA-mRNA co-expression network affecting EMT-mediated cisplatin resistance in ovarian cancer[J].J Cell Mol Med,2022,26(16):4530-4547.
[15] ZHANG F,LUO BH,WU QH,et al.LncRNA HCG18 upregulates TRAF4/TRAF5 to facilitate proliferation,migration and EMT of epithelial ovarian cancer by targeting miR-29a/b[J].Mol Med,2022,28(1):2.
[16] 陈立兰,狄文.柠檬酸合成酶对卵巢癌SKOV3细胞上皮间质转化的影响[J].现代肿瘤医学,2022,30(17):3065-3068.
CHEN Lilan,DI Wen.Influence of citrate synthase on epithelial-mesenchymal transformation of ovarian cancer SKOV3 cells[J].Modern Oncology,2022,30(17):3065-3068.
[17] 吕小慧,陈必良.上皮间质转化在卵巢癌进展及化疗耐药中的研究进展[J].现代肿瘤医学,2020,28(20):3609-3613.
LYU Xiaohui,CHEN Biliang.The progress of epithelial-to-mesenchymal transition in ovarian cancer and chemotherapy resistance[J].Modern Oncology,2020,28(20):3609-3613.